Drugs that contain Octreotide Acetate

1. Drug name - MYCAPSSA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9265812 AMRYT Pharmaceutical compositions and related methods of delivery Sep, 2029

(6 years from now)

US9566246 AMRYT Pharmaceutical compositions and related methods of delivery Sep, 2029

(6 years from now)

US8329198 AMRYT Pharmaceutical compositions and related methods of delivery Sep, 2029

(6 years from now)

US8535695 AMRYT Pharmaceutical compositions and related methods of delivery Sep, 2029

(6 years from now)

US11052126 AMRYT Method of treating diseases Feb, 2036

(13 years from now)

US10695397 AMRYT Method of treating diseases Feb, 2036

(13 years from now)

US10238709 AMRYT Method of treating diseases Feb, 2036

(13 years from now)

US11141457 AMRYT Oral octreotide therapy and contraceptive methods Dec, 2040

(18 years from now)

Treatment: Use of oral octreotide for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide; Use of oral octreotide for long-term maintenance treatment in acromegaly patients while avoiding concomitant administration of levonorgestrel

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 20MG BASE CAPSULE, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.